Chlorthalidone: Difference between revisions
| [unchecked revision] | [unchecked revision] |
MDElliottMD (talk | contribs) parser-claude batch MedTemplate pre-fill, Top 300 #124 |
MDElliottMD (talk | contribs) home-claude category backfill (parser-claude gap closure) |
||
| Line 21: | Line 21: | ||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Thiazide-like diuretics]] | |||
[[Category:Antihypertensives]] | |||
Latest revision as of 10:43, 23 May 2026
Chlorthalidone
Thalitone; mostly prescribed generically
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Common uses
Hypertension0, Edema0, Nephrogenic diabetes insipidus0
Pharmacy
Starting dose
12.5-25 mg PO once daily; titrate to 50 mg
Preparations
15 mg, 25 mg, 50 mg tablets
US FDA Max
100 mg/d (rarely used)
Pharmacology
Routes
Oral
Onset
Diuresis at 2-3 hours; BP effect over weeks
Duration
48-72 hours per dose (much longer than hydrochlorothiazide)
Half-life
40-60 hours (notable for the thiazide class)[1]
Bioavailability
~65% (oral)[1]
Pregnancy
Avoided where possible; same class concerns as HCTZ.[citation needed]
Legal status
Rx-only in US
Purported mechanism
Chlorthalidone inhibits the Na+/Cl- cotransporter (NCC) in the distal convoluted tubule, producing the same natriuretic and vasodilatory effects as hydrochlorothiazide but with a substantially longer half-life that yields more sustained 24-hour BP control and modest evidence of better cardiovascular outcomes (ALLHAT, SHEP).0 Despite the favorable trial data, hydrochlorothiazide remains the dominant US thiazide prescription due to pricing and habit. Hyponatremia, hypokalemia, hypomagnesemia, hyperuricemia, hyperglycemia, and erectile dysfunction are characteristic class effects[1].
References
- ↑ 1.0 1.1 1.2 FDA Prescribing Information, chlorthalidone tablets, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012109s015lbl.pdf